Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine

Clinical Cancer Research

Volumn 14, Issue 5, 2008, Pages 1377-1385

  Jennewein, Marc ^a,b   Lewis, Matthew A ^b,c   Zhao, Dawen ^b   Tsyganov, Edward ^b   Slavine, Nikolai ^b   He, Jin ^b,c   Watkins, Linda ^b,c   Kodibagkar, Vikram D ^b   O'Kelly, Sean ^e   Kulkarni, Padmakar ^b   Antich, Peter P ^b   Hermanne, Alex ^d   Rösch, Frank ^a   Mason, Ralph P ^b,c   Thorpe, Philip E ^b,c  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^e UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; BAVITUXIMAB; CHIMERIC ANTIBODY; PHOSPHATIDYLSERINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG HALF LIFE; GAMMA SCINTIGRAPHY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MOLECULAR IMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE TUMOR; RAT; SOLID TUMOR; TUMOR DIAGNOSIS; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIBODIES, MONOCLONAL; ARSENIC; ENDOTHELIUM, VASCULAR; MALE; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHATIDYLSERINES; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; RADIOIMMUNODETECTION; RADIOISOTOPES; RATS; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 40949141332     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-1516     Document Type: Article

References (37)

1. Rudin M, Weissleder R. Molecular imaging in drug discovery and development. Nat Rev Drug Discov 2003;2:123-31.
2. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003;17:545-80.
3. Kumar R, Jana S. Positron emission tomography: an advanced nuclear medicine imaging technique from research to clinical practice. Methods Enzymol 2004;385:3-19.
4. McQuade P, Rowland DJ, Lewis JS, Welch MJ. Positron-emitting isotopes produced on biomedical cyclotrons. Curr Med Chem 2005;12:807-18.
5. Boerman OC, Kopp MJ, Postema EJ, Corstens FH, Oyen WJ. Radionuclide therapy of cancer with radiolabeled antibodies. Curr Med Chem Anti-Canc Agents 2007;7:335-43.
6. Burnham CA, Aronow S, Brownell GL. A hybrid positron scanner. Phys Med Biol 1970;15:517-28.
7. Jennewein M, Qaim SM, Hermanne A, et al. A new method for the radiochemical separation of arsenic from reactor and cyclotron irradiated germanium oxide. Appl Rad Isoto 2005;63:343-51.
8. Jennewein M, Schmidt A, Novgorodov AF, Qaim SM, Roesch F. A no-carrier-added 72Se/72As radionuclide generator based on distillation. Radiochim Acta 2004;92:245-9.
9. Huang X, Bennett M, Thorpe PE. A monoclonal antibody that binds anionic phospholipids on tumor blood vessels enhances the antitumor effect of docetaxel on human breast tumors in mice. Cancer Res 2005;65:4408-16.
10. Ran S, Downes A, Thorpe PE. Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res 2002;62:6132-40.
11. Ran S, Thorpe PE. Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy. Int J Radiat Oncol Biol Phys 2002;54:1479-84.
12. Luster TA, He J, Huang X, et al. Plasma protein β-2-glycoprotein 1 mediates interaction between the anti-tumor monoclonal antibody 3G4 and anionic phospholipids on endothelial cells. J Biol Chem 2006;281:29863-71.
13. Ran S, Gao B, Duffy S, Watkins L, Rote N, Thorpe PE. Infarction of solid Hodgkin's tumors in mice by antibody-directed targeting of tissue factor to tumor vasculature. Cancer Res 1998;58:4646-53.
14. Ran S, He J, Huang X, Soares M, Scothorn D, Thorpe PE. Anti-tumor effects of a monoclonal antibody directed against anionic phospholipids on the surface of tumor blood vessels in mice. Clin Cancer Res 2005;11:1551-62.
15. Seigneuret M, Devaux PF. ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: relation to shape changes. Proc Natl Acad Sci U S A 1984;81:3751-5.
16. Bombeli T, Karsan A, Tait JF, Harlan JM. Apoptotic vascular endothelial cells become procoagulant. Blood 1997;89:2429-42.
17. Boyle EM, Jr., Pohlman TH, Cornejo CJ, Verrier ED. Endothelial cell injury in cardiovascular surgery: ischemia-reperfusion. Ann Thorac Surg 1996;62:1868-75.
18. Bevers EM, Comfurius P, Zwaal RF. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 1983;736:57-66.
19. Rote NS, Ng AK, Dostal-Johnson DA, Nicholson SL, Siekman R. Immunologic detection of phosphatidylserine externalization during thrombin-induced platelet activation. Clin Immunol Immunopathol 1993;66:193-200.
20. Bitbol M, Fellmann P, Zachowski A, Devaux PF. Ion regulation of phosphatidylserine and phosphatidylethanolamine outside-inside translocation in human erythrocytes. Biochim Biophys Acta 1987;904:268-82.
21. Zhao J, Zhou Q, Wiedmer T, Sims PJ. Level of expression of phospholipid scramblase regulates induced movement of phosphatidylserine to the cell surface. J Biol Chem 1998;273:6603-6.
22. Hamon Y, Broccardo C, Chambenoit O, et al. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat Cell Biol 2000;2:399-406.
23. Pradhan D, Williamson P, Schlegel RA. Phosphatidylserine vesicles inhibit phagocytosis of erythrocytes with a symmetric transbilayer distribution of phospholipids. Mol Membr Biol 1994;11:181-7.
24. Balasubramanian K, Schroit AJ. Aminophospholipid asymmetry: a matter of life and death. Annu Rev Physiol 2003;65:701-34.
25. Duncan RJ, Weston PD, Wrigglesworth R. A new reagent which may be used to introduce sulfhydryl groups into proteins, and its use in the preparation of conjugates for immunoassay. Anal Biochem 1983;132:68-73.
26. Henke K, Hartmann GH, Peschke P, Hahn EW. Stereotactic radiosurgery of the rat Dunning R3327-1 prostate tumor. Int J Radiat Oncol Biol Phys 1996;36:385-91.
27. Zhao D, Ran S, Constantinescu A, Hahn EW, Mason RP. Tumor oxygen dynamics: correlation of in vivo MRI with histological findings. Neoplasia 2003;5:308-18.
28. Modestou M, Puig-Antich V, Korgaonkar C, Eapen A, Quelle DE. The alternative reading frame tumor suppressor inhibits growth through p21-dependent and p21-independent pathways. Cancer Res 2001;61:3145-50.
29. Tsyganov EN, Anderson J, Arbique G, et al. UTSW small animal positron emission imager. IEEE Trans Nucl Inst 2006;53:2591-600.
30. Bischof Delaloye A, Delaloye B. Tumor imaging with monoclonal antibodies. Semin Nucl Med 1995;25:144-64.
31. Von Kleist S. Ten years of tumor imaging with labelled antibodies. In vivo 1993;7:581-4.
32. Karam JA, Mason RP, Koeneman KS, Antich PP, Benaim EA, Hsieh JT. Molecular imaging in prostate cancer. J Cell Biochem 2003;90:473-83.
33. Jiang L, Zhao D, Constantinescu A, Mason RP. Comparison of BOLD contrast and Gd-DTPA dynamic contrast enhanced imaging in rat prostate tumor. Magn Reson Med 2004;51:953-60.
34. Zhao D, Jiang L, Hahn EW, Mason RP. Continuous low-dose (Metronomic) chemotherapy on rat prostate tumors evaluated using MRI in vivo and comparison with histology. Neoplasia 2005;7:678-87.
35. Beck AW, Luster TA, Miller AF, et al. Combination of a monoclonal anti-phosphatidylserine antibody with gemcitabine strongly inhibits the growth and metastasis of orthotopic pancreatic tumors. Int J Cancer 2006;118:2639-43.
36. He J, Luster TA, Thorpe PE. Radiation-enhanced vascular targeting of human lung cancers in mice with a monoclonal antibody that binds anionic phospholipids. Clin Cancer Res 2007;207:5211-8.
37. Hahn EW, Peschke P, Mason RP, Babcock EE, Antich PP. Isolated tumor growth in a surgically formed skin pedicle in the rat: a new tumor model for NMR studies. Magn Reson Imaging 1993;11:1007-17.